Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.
Kragsnaes MS, Gilbert BTP, Sofíudóttir BK, Rooney CM, Hansen SM, Mauro D, Mullish BH, Bergot AS, Mankia KS, Goel N, Bakland G, Johnsen PH, Miguens Blanco J, Li S, Dumas E, Lage-Hansen PR, Wagenaar C, Bakdash G, Robinson M, Kristiansen K, Marchesi JR, Schett G, Zaiss MM, Orlu M, van Schaadenburg D, Scher JU, McGonagle D, Elewaut D, Breban M, Tugwell P, Finckh A, Ciccia F, Kriegel MA, Daien C, Ellingsen T, Christensen R; EULAR Study Group MICMUC.
Kragsnaes MS, et al. Among authors: gilbert btp.
BMJ Open. 2025 Dec 14;15(12):e101593. doi: 10.1136/bmjopen-2025-101593.
BMJ Open. 2025.
PMID: 41397742
Free PMC article.